Savara Inc (NASDAQ:SVRA) Q2 2020 Results Conference Call August 6, 2020 4:30 PM ET Company Participants Anne Erickson - Head Investor Relations Robert Neville - Chief Executive Officer Badrul Chowdhury - Chief Medical Officer Taneli Jouhikainen - President and Chief Business Officer David Lowrance - Chief Financial Officer Operator Welcome to the Savara conference call. At this time, all participants are in a listen-only mode. An audio webcast of this call will be available on the Investors section of Sava ...

Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from to Commission File Number 001-32157 Savara Inc. (Exact name of registrant as specified in its charter) Delaware 84-1318182 (State or other jurisdiction of inco ...

Savara Inc. (NASDAQ:SVRA) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Anne Erickson - VP, IR and Corporate Communications Rob Neville - CEO Badrul Chowdhury - Chief Medical Officer Dave Lowrance - CFO Taneli Jouhikainen - COO Conference Call Participants Edward Marks - Ladenburg Thalmann Suji Jeong - Jefferies Liisa Bayko - JMP Securities Operator Good day and welcome to the Savara conference call. At this time, all participants are in a listen-only mode. An audio webcast of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32157 Savara Inc. (Exact name of registrant as specified in its charter) Delaware 84-1318182 (State or other jurisdiction of inc ...

Savara Corporate Presentation (NASDAQ: SVRA) March 2020 Safe Harbor Statement 2 Savara Inc. ("Savara" or the "Company") cautions you that statements in this presentation that are not a description of historical fact are forward-looking statements which may be identified by the use of words such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Such statements include, but are not limited to, statements regarding the timing of studies, data, completion of enrollment and other ...

Savara Inc. (NASDAQ:SVRA) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants Anne Erickson - Vice President of Investor Relations and Corporate Communications Rob Neville - Chief Executive Officer Badrul Chowdhury - Chief Medical Officer Taneli Jouhikainen - Chief Operating Officer Dave Lowrance - Chief Financial Officer Conference Call Participants Josh Schimmer - Evercore ISI Suji Jeong - Jefferies LLC Operator Welcome to the Savara conference call. At this time, all participa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-32157 Savara Inc. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorporation or organizatio ...

Savara Inc. (NASDAQ:SVRA) Q3 2019 Results Conference Call November 7, 2019 4:30 PM ET Company Participants Anne Erickson - Head of Investor Relations Rob Neville - Chief Executive Officer Taneli Jouhikainen - President and Chief Operating Officer Dave Lowrance - Chief Financial Officer Operator Welcome to the Savara conference call. [Operators Instructions] An audio webcast of this call will be available on the Investors section of Savara's website at savarapharma.com. This call is subject to copyright an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32157 Savara Inc. (Exact name of registrant as specified in its charter) Delaware 84-1318182 (State or other jurisdiction of ...

SAVARA CORPORATE PRESENTATION (NASDAQ: SVRA) AUGUST 2019 SAFE HARBOR STATEMENT Savara Inc. ("Savara" or the "Company") cautions you that statements in this presentation that are not a description of historical fact are forward-looking statements which may be identified by the use of words such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Such statements include, but are not limited to, statements regarding the timing of studies, data, completion of enrollment and other m ...